{"filing":{"accession_number":"0001111928-26-000142","cik":"0001111928","ticker":"IPGP","company_name":"IPG PHOTONICS CORP","form":"8-K","filing_date":"2026-07-17","report_date":null,"primary_document":"ipgp-20260716.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000142/ipgp-20260716.htm"},"events":[{"id":18561,"run_id":16686,"accession_number":"0001111928-26-000142","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"IPG Photonics entered into a binding Put Option Agreement on July 16, 2026, to acquire 100% of Lumibird Medical for €300 million plus up to €50 million in contingent earnout consideration on a cash-free, debt-free basis, with expected closing in Q4 2026. The acquisition is expected to expand IPG's Advanced Solutions portfolio, create a scaled medical laser platform, and be accretive to gross margin, EBITDA, and adjusted EPS.","company_name":"IPG PHOTONICS CORP","ticker":"IPGP","filing_date":"2026-07-17","form":"8-K","submitted_at":null,"items":[{"id":17405,"accession_number":"0001111928-26-000142","item_number":"1.01","item_title":"Entry in a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"IPG Photonics entered into a binding Put Option Agreement on July 16, 2026, relating to the acquisition of 100% of Lumibird Medical for €300 million plus up to €50 million in contingent earnout consideration. The filing discloses a material definitive agreement for a proposed acquisition with a purchase price of €300 million on a cash-free, debt-free basis, expected to close in Q4 2026. This constitutes entry into a material acquisition transaction under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-17T10:31:48.894964+00:00","company_name":"","ticker":null,"filing_date":""},{"id":17406,"accession_number":"0001111928-26-000142","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"IPG Photonics announced entry into a binding offer to acquire Lumibird Medical for €300 million plus contingent earnout of up to €50 million. The press release and supplemental presentation describe this as a material acquisition that expands IPG's Advanced Solutions portfolio, creates a scaled medical laser platform, and is expected to be accretive to gross margin, EBITDA, and adjusted EPS. This is a clear material acquisition activity disclosed under Item 7.01 (Regulation FD Disclosure) via press release and investor presentation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-17T10:31:48.894964+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17405,"accession_number":"0001111928-26-000142","item_number":"1.01","item_title":"Entry in a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"IPG Photonics entered into a binding Put Option Agreement on July 16, 2026, relating to the acquisition of 100% of Lumibird Medical for €300 million plus up to €50 million in contingent earnout consideration. The filing discloses a material definitive agreement for a proposed acquisition with a purchase price of €300 million on a cash-free, debt-free basis, expected to close in Q4 2026. This constitutes entry into a material acquisition transaction under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-17T10:31:48.894964+00:00","company_name":"IPG PHOTONICS CORP","ticker":"IPGP","filing_date":"2026-07-17"},{"id":17406,"accession_number":"0001111928-26-000142","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"IPG Photonics announced entry into a binding offer to acquire Lumibird Medical for €300 million plus contingent earnout of up to €50 million. The press release and supplemental presentation describe this as a material acquisition that expands IPG's Advanced Solutions portfolio, creates a scaled medical laser platform, and is expected to be accretive to gross margin, EBITDA, and adjusted EPS. This is a clear material acquisition activity disclosed under Item 7.01 (Regulation FD Disclosure) via press release and investor presentation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-17T10:31:48.894964+00:00","company_name":"IPG PHOTONICS CORP","ticker":"IPGP","filing_date":"2026-07-17"}]}